Skip to content
DraconiticResearch
Search Sources API
220,472 studies31 sourcesUpdated 7 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Atom feed
Filters
Type
Date
Clear

Latest

5,770 studies

NewestMost cited
  1. Assessing diagnostic performance for common skin diseases using an AI-assisted tele-expertise platform: a proof of concept
    Florine Le Lay, Ouriel Barzilay, Damiano Cerasuolo +6
    European Journal of DermatologyPeer-reviewedCC BY-NC-NDFull text5 citedOncologyHAL
  2. Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer
    Katherine Elizabeth Francis, Sandy Simon, Val Gebski +14
    Gynecologic OncologyPeer-reviewedCC BY2 citedOncologyHAL
  3. Rational Use of Herbal Products in Pediatric Patients Treated With Anticancer Drugs in the European Union
    Orianne Mahot, Mathieu Corvaisier, Laurence Spiesser‐robelet +4
    Pediatric Blood and CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPharmacology & toxicologyObstetrics, gynaecology & paediatricsHAL
  4. Sequence and structural determinants of efficacious de novo chimaeric antigen receptors
    Arthur Chow, Hoyin Chu, Ruofan Li +6
    Nature Biomedical EngineeringPeer-reviewedCC BY12 citedOncologyOpenAlex
  5. Network based approach identifies miR ‐145‐3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma
    Anna Citarella, Manuela Petti, Zein Mersini Besharat +22
    The Journal of PathologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  6. Cereus savings—successful use of dalbavancin in an immunocompromised patient with Bacillus cereus bacteremia
    Daisy L. Eaton, Matthew Stack, Robin Chamberland +1
    ASM case reportsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  7. A serpin–myeloid axis in pancreatic cancer heterogeneity and immune evasion
    Chiara Falcomatà, Maximilian M. Schaefer, Bhavya Singh +10
    NaturePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  8. Glucocorticoids reprogram human AML leukemic stem cells to promote elimination through differentiation and apoptosis
    I. A. Iasenza, Y. L. Sun, L. Best +11
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  9. HrasG12V induces follicular thyroid cancer with attenuated MAPK activation and increased latency compared to KrasG12D
    N. E. Bambach, K. Labella, L. A. Jolly +4
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  10. Molecular Editing in Protein Degradation: From a Dual NSD2/GSPT1 Degrader to an NSD2-Selective PROTAC and a GSPT1-Selective Molecular Glue
    W. Shen, Y. Liu, L. Liu +15
    bioRxivPreprintCC BYFull textOncologybioRxiv
  11. Glycometabolic, inflammatory and exocrine plasma proteins predict cancer in individuals with cardiovascular disease
    M. Fidelle, D. Boulate, T.-N. Pham +19
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  12. Repeat element-anchored enhancer-promoter interactions (REEPIs) shape the regulatory landscape of hormone-resistant breast cancer
    X. SHU, S. Ni, M. Murata +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  13. Characterisation of prostate cancer sialome re-engineering via CMAH transfection reveals a bystander effect that propagates Neu5Gc presentation to neighbouring cells
    Y. Uno, A. Noble, E. Hutton +2
    bioRxivPreprintCC BYFull textOncologybioRxiv
  14. A Versatile Microfluidic Device for High-throughput Combinatorial Drug Screening
    S. Jaiswal, M. P. Reddy, D. Paul +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  15. A combined program of induced stemness and differentiation in response to interferon gamma drives acute myeloid leukaemia growth
    C. Pospori, A. Donada, H. Boutzen +38
    bioRxivPreprintCC BYFull textOncologybioRxiv
  16. Discovery of compounds targeting human acute myeloid leukemia stem cells via a novel high-throughput screen
    I. A. Iasenza, S. Safa-Tahar-Henni, H. Dakik +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  17. Matched marrow and blood profiling reveals compartment- and feature-specific liquid-biopsy signals in multiple myeloma
    D. D. Abelman, J. Eagles, S. Pedersen +14
    medRxivPreprintCC BYFull textOncologymedRxiv
  18. Gut microbiome alterations predictive of cancer risk
    G. Vitali, J. R. Bjork, O. Kambur +23
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  19. Sequencing of Stereotactic Body Radiation Therapy and Chemotherapy in Stage I Small Cell Lung Cancer: Practice Patterns and Outcomes
    Therese J. Ziaks, Patrick Oh, Daniel Hicks +5
    Advances in Radiation OncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMCEurope PMC
  20. Impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study
    Melissa Lagger, Hugo Najberg, Almir Miftaroski +11
    PLOS OnePeer-reviewedCC BY 4.0Full textEndocrinology & metabolismMedical imaging & radiologyOncologyPLOS
  21. A Latent profile and network intervention analysis of psychosomatic symptoms in lung cancer immunotherapy patients
    Danwen Zheng, Hang Gao, Yanfei Zou +4
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPsychiatry & mental healthPLOS
  22. Cervical leukoplakia in Ghana: Unveiling diagnostic challenges and informing low-resource screening strategies
    Kofi Effah, Ethel Tekpor, Maxwell Afetor +10
    PLOS OnePeer-reviewedCC BY 4.0OncologyPLOS
  23. ANCA testing strategies: A single centre experience over the past decade in a large teaching hospital in the Netherlands
    Maria A. C. Wester Trejo, Tjallingius Martijn Kuijper, Geeke J. Waverijn +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  24. Long-term comparative trajectories of health, behavioral, and economic outcomes: From pre-diagnosis to survivorship
    Hui G. Cheng, Livingstone Aduse-Poku, Oxana Palesh +1
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPLOS
  25. Clinicopathological characteristics and prognosis of melanoma: A retrospective cohort study in Xinjiang, China
    Caoying Wu, Yongting Yang, Chun Wang +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS